Peripheral neuropathies during biologic therapies

A case of peripheral neuropathy and skin ulcer in a patient with rheumatoid arthritis after a single infusion of tocilizumab

(2014) Fumiaki Sugiura et al.   Modern Rheumatology

Total knee arthroplasty for massive joint destruction in a patient with rheumatoid arthritis complicated with fibrous dysplasia

(2014) Takeshi Mochizuki et al.   Modern Rheumatology

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients

(2014) Takao Koike et al.   Modern Rheumatology

Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey

(2013) Raphaèle Seror et al.   RHEUMATOLOGY

Neurological Deficits During Treatment With Tumor Necrosis Factor-Alpha Antagonists

(2011) Kenkichi Nozaki et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients

(2011) T. Koike et al.   ANNALS OF THE RHEUMATIC DISEASES

Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors

(2011) Andrew J Solomon et al.   Multiple Sclerosis Journal

Monoclonal antibody therapy-associated neurological disorders

(2011) Xavier Bosch et al.   Nature Reviews Neurology

Neurological adverse events associated with anti-tumor necrosis factor alpha treatment

(2010) Antonio G. Tristano   JOURNAL OF NEUROLOGY

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Revision

(2010)   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-α antagonists

(2010) Amer Alshekhlee et al.   MUSCLE & NERVE

Long-term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-α–Blocker Therapy

(2009) Pierre Lozeron et al.   ARCHIVES OF NEUROLOGY

A case of spontaneously recovering multifocal motor neuropathy with conduction blocks (MMNCB) during anti-TNF alpha therapy for ankylosing spondylitis

(2009) Giuseppe Paolazzi et al.   CLINICAL RHEUMATOLOGY

Guillain–Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy

(2009) Amine Bouchra et al.   CLINICAL RHEUMATOLOGY

Acute bilateral phrenic neuropathy following treatment with adalimumab

(2009) Alexandra Alexopoulou et al.   CLINICAL RHEUMATOLOGY

Axonal Common Peroneal Nerve Palsy and Delayed Proximal Motor Radial Conduction Block Following Infliximab Treatment

(2009) Andreas A. Argyriou et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan

(2009) T. KOIKE et al.   JOURNAL OF RHEUMATOLOGY

Peripheral neuropathy in two patients with psoriasis in treatment with infliximab

(2009) Cristina Eguren et al.   MUSCLE & NERVE

Miller–Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab

(2008) Patric Thierry Kurmann et al.   CLINICAL RHEUMATOLOGY

Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis

(2008) Davyd R. Hooper et al.   MUSCLE & NERVE

Tumor necrosis factor-α antagonists and neuropathy

(2007) Joerg-Patrick Stübgen   MUSCLE & NERVE